Deciphering the genetics of primary angioedema with normal levels of C1 inhibitor

Autor: Loules, G. Parsopoulou, F. Zamanakou, M. Csuka, D. Bova, M. González-Quevedo, T. Psarros, F. Porebski, G. Speletas, M. Firinu, D. del Giacco, S. Suffritti, C. Makris, M. Vatsiou, S. Zanichelli, A. Farkas, H. Germenis, A.E.

The genetic alteration underlying the great majority of primary angioedema with normal C1 inhibitor (nl-C1-INH-HAE) cases remains unknown. To search for variants associated with nl-C1-INH-HAE, we genotyped 133 unrelated nl-C1-INH-HAE patients using a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::aeb29b361a1e9136ecad3cb72399dd1c
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3103633

Les angio-œdèmes héréditaires à kinines : nécessité d’une refondation de leur classification, à propos de 4 familles

Autor: Vincent, D., Parsopoulou, F., Ghanam, A., Charignon, D., Cichin, S., Germenis, A.E., Drouet, C.

Publikováno v: In La revue de médecine interne December 2018 39 Supplement 2:A24-A25

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Searching for Genetic Biomarkers for Hereditary Angioedema Due to C1-Inhibitor Deficiency (C1-INH-HAE).

Autor: Parsopoulou F; Department of Immunology and Histocompatibility, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece., Loules G; CeMIA SA, Larissa, Greece., Zamanakou M; CeMIA SA, Larissa, Greece., Csuka D; Department of Internal Medicine and Haematology, Hungarian Angioedema Center of Reference and Excellence, Semmelweis University, Budapest, Hungary., Szilagyi A; Department of Internal Medicine and Haematology, Hungarian Angioedema Center of Reference and Excellence, Semmelweis University, Budapest, Hungary., Kompoti M; Department of Immunology and Histocompatibility, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece., Porebski G; Department of Clinical and Environmental Allergology, Jagiellonian University Medical College, Krakow, Poland., Psarros F; Department of Allergology, Navy Hospital, Athens, Greece., Magerl M; Institute of Allergology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany., Valerieva A; Department of Allergology, Clinic of Allergology, University Hospital 'Alexandrovska', Medical University of Sofia, Sofia, Bulgaria., Staevska M; Department of Allergology, Clinic of Allergology, University Hospital 'Alexandrovska', Medical University of Sofia, Sofia, Bulgaria., Obtulowicz K; Department of Clinical and Environmental Allergology, Jagiellonian University Medical College, Krakow, Poland., Maurer M; Institute of Allergology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany., Speletas M; Department of Immunology and Histocompatibility, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece., Farkas H; Department of Internal Medicine and Haematology, Hungarian Angioedema Center of Reference and Excellence, Semmelweis University, Budapest, Hungary., Germenis AE; Department of Immunology and Histocompatibility, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece.; CeMIA SA, Larissa, Greece.

Publikováno v: Frontiers in allergy [Front Allergy] 2022 Jul 07; Vol. 3, pp. 868185. Date of Electronic Publication: 2022 Jul 07 (Print Publication: 2022).